1. The Type 1 Diabetes–Resistance Locus Idd22 Controls Trafficking of Autoreactive CTLs into the Pancreatic Islets of NOD Mice
   Robert L. Whitener et al, 2017, The Journal of Immunology CrossRef
2. The influence of exendin-4 intervention on -obese diabetic mouse blood and the pancreatic tissue immune microenvironment
   Jinshui He et al, 2016, Experimental and Therapeutic Medicine CrossRef
3. Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes
   Lucas H. Armitage et al, 2021, Frontiers in Endocrinology CrossRef
4. Epigallocatechin Gallate Targeting of Membrane Type 1 Matrix Metalloproteinase-mediated Src and Janus Kinase/Signal Transducers and Activators of Transcription 3 Signaling Inhibits Transcription of Colony-stimulating Factors 2 and 3 in Mesenchymal Stromal Cells
   Alain Zgheib et al, 2013, Journal of Biological Chemistry CrossRef
5. Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
   Gustavo Ortiz et al, 2014, Biological Research CrossRef
6. Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasionin vitroand metastasisin vivo
   Kenneth A. Botkjaer et al, 2016, Oncotarget CrossRef